Survival rates of children with cancer continue to increase
The survival rate of children with cancer continues to rise, according to figures published by IKNL. Healthcare professionals and scientists at the Princess Máxima Center remain committed to curing even more children with cancer and improving the quality of life of children and survivors.
Compared to the period 1990-1999, the survival rate of children diagnosed with cancer in 2010 through 2018 is markedly higher. For diagnoses during the latter period, the survival rate was 84 percent, up from 74 percent in the 1990s.
‘It is good to see that survival in childhood cancer has continued to increase,’ Prof. Dr. René Medema, Chief Scientific Officer, says of the new IKNL figures. ‘In several forms of leukemia, such as AML and ALL, we see the largest increase thanks to a sum of many different improvements. But across the board, there are still too many children with an extremely poor prognosis: the most difficult-to-treat tumors remain. That is why it is so important to continue to join forces of healthcare professionals and researchers within the Netherlands, within Europe and worldwide. Only together can we achieve the breakthroughs needed to cure all children with cancer, with optimal quality of life.’
Following the new figures, pediatric oncologist dr. Wouter Kollen and pediatric neurosurgeon prof. dr. Eelco Hoving gave an interview to the AD newspaper. Among other things, they talked about the strides being made with immunotherapy for treatment of leukemia, how new technology lets doctors operate better, and approaches to permanently improve the quality of life of children and survivors.
IKNL’s full press release can be found here. The AD interview is here.
Princess Máxima Center and International Atomic Energy Agency join forces to improve radiotherapy treatments for children
In the presence of Her Majesty Queen Máxima, representatives of the Princess Máxima Center and the International Atomic Energy Agency (IAEA) today signed a four-year partnership aimed at improving practical knowledge on the use of radiotherapy for children with cancer.
MedTech sector launches national growth plan: technology must support Dutch healthcare and structurally strengthen economic growth
The Dutch MedTech sector is presenting an ambitious growth plan today that aims to elevate the Netherlands to the European top by 2035. UMC Utrecht contributed to this plan, and it was co-presented by Carina Hilders (Chair of the UMC Utrecht Executive Board).
Parking rates at Utrecht Science Park to change from 1 January 2026
From 1 January 2026, parking rates at Utrecht Science Park will be adjusted. The Municipality of Utrecht and the owners of the publicly accessible parking facilities at Utrecht Science Park have reached a joint agreement on this.
Wennink plan: Life Sciences and biotechnology are important growth drivers for the earning capacity of the Netherlands
The Dutch Life Sciences and biotechnology sector can make a much larger contribution to the Netherlands’ economic strength. This is shown in a new growth strategy presented today as part of Peter Wennink’s advisory report. The report also highlights Utrecht Science Park as one of the key innovation locations and sources of progress and growth.